Hyperglycemia attenuates acute permeability response to advanced glycation end products in retinal microvasculature.
Warboys
C M
CM
Cardiovascular Division, King's College London, London, UK.
Fraser
P A
PA
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects*; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000378:metabolism / Q000503:physiopathology*; D005456:Fluorescent Dyes / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D017127:Glycation End Products, Advanced / Q000494:pharmacology*; D006943:Hyperglycemia / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D011924:Rats, Zucker; D012160:Retina / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D012235:Rhodamines / Q000378:metabolism; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology
D001786:Blood Glucose; D005456:Fluorescent Dyes; D017127:Glycation End Products, Advanced; D012235:Rhodamines; C081628:advanced glycation end products-bovine serum albumin; C022027:lissamine rhodamine B; D012710:Serum Albumin, Bovine; D013395:Sucrose; D005947:Glucose; D001920:Bradykinin